Bristol-Myers Squibb Scheduled to Report Q3 2026 Earnings
Bristol-Myers Squibb (BMY) is set to release its third-quarter 2026 financial results on Thursday, October 29th, prior to the market opening. Analysts are closely watching for performance metrics as the company navigates shifting revenue streams. The consensus estimates for the quarter project earnings per share (EPS) of $1.22, representing a significant year-over-year decline of 25.2%. However, revenue is expected to grow by 4.2% year-over-year to approximately $12.73 billion.
Tickers: $BMY